When exploring the world of synthetic analogs and biochemical research, the dotatate peptide sequence stands out as a subject of significant interest. As an enthusiast who closely follows developments in peptide chemistry, I have spent considerab Peptide Receptor Radionuclide Therapy with 177Lu- le time reviewing the structural nuances of this molecule. Understanding its composition is essential for anyone looking to grasp how Peptide sequence:DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr(cyclic disulfide) DOTA-TATE peptide is derived from octreotate, a close analog of octreotide Read more these specialized structures function in laboratory settings.
The Structural Composition of DOTATATE
At its core, DOTATATE is a derivatized somatostatin analogue peptide. The technical nomenclature often refers to it as DOTA-(Tyr3)-octreotate. To understand the molecule, one must look at the specific arrangement of its building blocks. The primary sequence is defined as:
{DOTA}-{d-Phe}-Cys-Tyr-{d-Trp}-Lys-Thr-Cys-Thr
This structure features a cyclic disulfide bridge between the two Cysteine (Cys) residues, which is a hallmark of its design. The inclusion of the DOTA (1,4,7,10-tetraazacyclododecane-1,4, Peptide receptor radionuclide therapy (PRRT) using177Lu-DOTA-TATEhas recently been evaluated for the treatment of meningioma patients. However, current Read more 7,10-tetraacetic acid) bifunctional chelator at the N-terminus is what allows this peptide to serve as a versatile tool in advanced research. The DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr configuration, when stabilized by that disulfide linkage, creates a robust framework that mimics natural somatostatin with high affinity for specific receptor subtypes.
Why the Sequence Matters
In my personal research into various compounds, I have found that the DOTATATE structure is engineered for precision. The "Tyr3" modification—the substitution of phenylalanine with tyrosine at the third position—is a critical detail in the DOTATATE framework. This modification is what distinguishes it from other analogs, such as DOTA-TOC.
When discussing 177Lu-DOTATATE, researchers are often focused on how the DOTA chelator holds onto metallic isotopes. The Lutetium Lu 177 dotatate complex is a prime example of how this 177 Lu-DOTATATE platform is utilized in high-level studi Dotatate | C65H90N14O19S2 | CID 11170867 - PubChem - NIH es. The molecular weight and the exact spatial orientation provided by the DOTA}-{d-Phe}-Cys-Tyr-{d-Trp}-Lys-Thr-Cys-Thr chain ensure that the molecule remains stable during compl by TA Hope·2019·Cited by 197—The amino acid solution should infuse concurrently with the.177Lu-DOTATATE, and continue at 320 mL/h or greater until the total volume has been administered.Read more ex experimental procedures.
Observations on Peptide Research
In the broader context of 177 Lu-DOTATATE therapy or g Guidance on 177 Lu-DOTATATE Peptide Receptor eneral 177Lu-DOTA-TATE investigations, the importance of purity and sequence accuracy cannot be overstated. Whether one is evaluating 177Lu]Lu-DOTA-TATE or studying the underlying 177 Lu-DOTATATE peptide receptor radionuclide therapy mechanisms, the integrity of the peptide chain is the foundational factor for success.
I have noted that the sequencing of experiments involving this molecule often requires a deep understanding of its binding kinetics. The 177Lu]Lu-[DOTA0,Tyr3]-octreotate (177Lu-DOTATATE) complex is highly regarded for its specificity. For those of us who track these developments, comparing DOTATATE to 177 Lu-DOTATOC highlights how small shifts in the amino acid chain—like the specific placement of the tyrosine residue—can alter affinity profiles in a laboratory environment.
Conclusion
The dotatate peptide sequence is a masterclass in biochemical engineering. By combining a cyclic, disulfide-bridged backbone with a DOTA chelator, it provides a stable, highly specific instrument for researchers. Whether you are analyzing the 177 Lu-DOT Gallium-68 DOTATATE | Radiology Reference Article | Radiopaedia.org ATATE therapy protocols or simply interested in the chemical architecture of somatostatin analogs, the precision of this peptide remains a fascinating topic. As always, when handling such specialized reagents, ensuring the correct sequence and high chemical purity is paramount for achieving consistent results in any rigorous scientific application.